Atlas Trials

Intravenous Thyroxine for Heart-Eligible Organ Donors

Clinical trial NCT04415658 · COMPLETED

Trial details

NCT number
NCT04415658
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Brain DeathHeart Failure
Start date
2020-12-01
Primary completion
2022-11-06
Enrollment
838

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.